ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

ASCO Urges Increase In Research Funding, Removal of Barriers For Trial Participation

January 23, 2009

CCIRC Okays New Effort To Rate Disease Committees, Modalities In Groups, Effective with Next Round

November 20, 1981

FDA News: Consolidation Plan Designed For Savings

June 5, 1998

Roswell Park’s Future “Bright” As Center Snares Leading Scientists, Hohn Says.

January 18, 2002

Mammography Had Limited Impact Among Swedish Women Age 40-69

July 27, 2012

HCFA Renamed In HHS Effort At Medicare, Medicaid Reform.

June 22, 2001